KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Return on Sales (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Return on Sales data on record, last reported at 0.02% in Q4 2025.

  • For Q4 2025, Return on Sales fell 1.0% year-over-year to 0.02%; the TTM value through Dec 2025 reached 0.0%, down 51.0%, while the annual FY2025 figure was 0.0%, 51.0% down from the prior year.
  • Return on Sales reached 0.02% in Q4 2025 per EW's latest filing, up from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 2.0% in Q3 2024 and bottomed at 0.01% in Q1 2025.
  • Average Return on Sales over 5 years is 0.23%, with a median of 0.04% recorded in 2023.
  • Peak YoY movement for Return on Sales: surged 196bps in 2024, then crashed -200bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.25% in 2021, then skyrocketed by 85bps to 0.47% in 2022, then tumbled by -94bps to 0.03% in 2023, then dropped by -2bps to 0.03% in 2024, then tumbled by -39bps to 0.02% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.02% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.